it is suggested that vinca alkaloid inhibition of monocyte phagocytosis is of value in the treatment of type ii-iii autoimmune disorders , such as idiopathic thrombocytopenic purpura and autoimmune haemolytic anaemia .
C0004364
autoimmune
C0398650
idiopathic thrombocytopenic purpura